Literature DB >> 176724

REM sleep induction by physostigmine infusion during sleep.

N Sitaram, R J Wyatt, S Dawson, J C Gillin.   

Abstract

Physostigmine (an anticholinesterase agent that increases acetylcholine at the synapse), in a dose of 0.5 milligram, was given intravenously to seven normal human volunteers. When injected during rapid eye movement (REM) sleep, physostigmine woke the subjects, and when injected during non-REM sleep, it induced REM sleep. This result suggests that cholinergic mechanisms play a role in the induction of REM sleep and in modulating cortical arousal mechanisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 176724     DOI: 10.1126/science.176724

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Low acetylcholine during slow-wave sleep is critical for declarative memory consolidation.

Authors:  Steffen Gais; Jan Born
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 3.  Acetylcholine and affective disorder.

Authors:  S S Leong; W A Brown
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG.

Authors:  L Gustafson; L Edvinsson; N Dahlgren; B Hagberg; J Risberg; I Rosén; H Fernö
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  EEG effects of physostigmine and choline chloride in humans.

Authors:  A Pfefferbaum; K L Davis; C L Coulter; R C Mohs; J R Tinklenberg; B S Kopell
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

6.  Endogenous GABA levels in the pontine reticular formation are greater during wakefulness than during rapid eye movement sleep.

Authors:  Giancarlo Vanini; Bradley L Wathen; Ralph Lydic; Helen A Baghdoyan
Journal:  J Neurosci       Date:  2011-02-16       Impact factor: 6.167

7.  Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers.

Authors:  J C Gillin; W Jernajczyk; D C Valladares-Neto; S Golshan; M Lardon; S M Stahl
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

Review 8.  Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Authors:  Christopher J Watson; Haideliza Soto-Calderon; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

9.  Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.

Authors:  D Riemann; F Hohagen; M Bahro; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

10.  REM sleep suppression induced by selective monoamine oxidase inhibitors.

Authors:  R M Cohen; D Pickar; D Garnett; S Lipper; J C Gillin; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.